Ouyang Yu-Long, Wei Jing, Liu Mei-Yan, Zhang Yi, Liu Sheng-Hui, Feng Hong-Chao
College of Stomatology, Guizhou Medical University, Guiyang, China.
Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
Front Oncol. 2024 Aug 22;14:1437493. doi: 10.3389/fonc.2024.1437493. eCollection 2024.
Several existing studies have shown a correlation between some of the blood and urine biomarkers and oral leukoplakia (OLK). However, the causality of this relationship remains uncertain. Thus, this study aimed to examine the causal association between 35 blood and urine biomarkers and OLK.
Single nucleotide polymorphisms (SNPs) associated with 35 blood and urine biomarkers were selected as instrumental variables (IVs) using a two-sample Mendelian randomization(MR) study to assess the causal relationship between the biomarkers and the risk of oral leukoplakia. We used the inverse variance weighted (IVW) method as the main analysis. Furthermore, several sensitivity analyses were performed to assess heterogeneity, horizontal pleiotropy, and stability.
Based on the selection criteria of the Inverse Variance Weighted (IVW) method, the analysis found that 5 blood and urine biomarkers were significantly associated with the development of leukoplakia, of which the results of IVW showed that abnormalities of Apolipoprotein B (Apo B), Cholesterol, Low-density Lipoprotein (LDL), Triglycerides (TG) promoted the development of oral leukoplakia, and Non Albumin Protein (NAP) had a protective effect on the development of oral leukoplakia. We then performed a Bonferroni correction for these results, and after correction Apo B was still causally associated with the development of oral leukoplakia (IVW P<0.0007), whereas the other four biomarkers could only provide some evidence of predisposition.
Our two-sample Mendelian randomization study supports the existence of a causal relationship between these five blood and urine biomarkers and the occurrence of oral leukoplakia, and provides evidence for a number of risk and protective factors for the development of oral leukoplakia; however, the definitive mechanisms for the occurrence and development of oral leukoplakia still remain to be elucidated, and further studies on these relevant mechanisms are still needed.
多项现有研究表明,一些血液和尿液生物标志物与口腔白斑(OLK)之间存在关联。然而,这种关系的因果性仍不确定。因此,本研究旨在探讨35种血液和尿液生物标志物与口腔白斑之间的因果关联。
使用两样本孟德尔随机化(MR)研究,选择与35种血液和尿液生物标志物相关的单核苷酸多态性(SNP)作为工具变量(IV),以评估这些生物标志物与口腔白斑风险之间的因果关系。我们采用逆方差加权(IVW)方法作为主要分析方法。此外,还进行了多项敏感性分析,以评估异质性、水平多效性和稳定性。
根据逆方差加权(IVW)方法的选择标准,分析发现5种血液和尿液生物标志物与白斑的发生显著相关,其中IVW结果显示,载脂蛋白B(Apo B)、胆固醇、低密度脂蛋白(LDL)、甘油三酯(TG)异常促进口腔白斑的发生,而非白蛋白蛋白(NAP)对口腔白斑的发生具有保护作用。然后我们对这些结果进行了Bonferroni校正,校正后Apo B仍与口腔白斑的发生存在因果关联(IVW P<0.0007),而其他四种生物标志物仅能提供一些易感性证据。
我们的两样本孟德尔随机化研究支持这五种血液和尿液生物标志物与口腔白斑发生之间存在因果关系,并为口腔白斑发生的一些风险和保护因素提供了证据;然而,口腔白斑发生和发展的确切机制仍有待阐明,仍需要对这些相关机制进行进一步研究。